Valneva’s Chikungunya Vaccine Candidate Awarded EMA Prime Designation

NEXT STORY
UPDATE – Trends in Psychedelic Drugs Research and Four Stocks You Should Know About
PREV STORY
ELI LILLY AND COMPANY ALERT: Bragar Eagel & Squire, P.C. is Investigating Eli Lilly and Company on Behalf of Eli Lilly Stockholders and Encourages Investors to Contact the Firm
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Saniona is Inviting Investors to Participate to a Presentation of the Positive Topline Results from the Phase 2 Trial: Tesomet for the Treatment of Hypothalamic Obesity

author_avatar
NASDAQ Market News

Cesca Therapeutics to Announce Financial Results for the First Quarter Ended March 31, 2018 and Host Conference Call on May 14

RANCHO CORDOVA, Calif., May 09, 2018 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (“Cesca” or ...

author_avatar
NASDAQ Market News

Loulo-Gounkoto Beats 2019 Guidance, Commits to New Decade of Delivery and Investment

author_avatar
NASDAQ Market News